P K Tandon - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

P K Tandon

Showing results (11-20 of 15) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 15 results.

The Science of the Total Environment|September 22, 2010

Face mask application as a tool to diminish the particulate matter mediated heavy metal exposure among citizens of Lucknow, IndiaM P Singh, V K Singh, D K Patel, et al.

The New England Journal of Medicine|October 24, 2008

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis, Alasdair J Coles, D Alastair S Compston, et al.

Orphanet Journal of Rare Diseases|March 12, 2015

Recommendations for the development of rare disease drugs using the accelerated approval pathway and for qualifying biomarkers as primary endpointsEmil D Kakkis, Mary O'Donovan, Gerald Cox, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|January 30, 2008

Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventionsChristopher G Goetz, Joanne Wuu, Michael P McDermott, et al.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 16, 2024

Nephrocalcinosis and kidney function in children and adults with X-linked hypophosphatemia: baseline results from a large longitudinal studyAnthony A Portale, Leanne Ward, Kathryn Dahir, et al.

Pageof 2

Search research articles

Showing results (11-20 of 15) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 15 results.

The Science of the Total Environment|September 22, 2010

Face mask application as a tool to diminish the particulate matter mediated heavy metal exposure among citizens of Lucknow, IndiaM P Singh, V K Singh, D K Patel, et al.

The New England Journal of Medicine|October 24, 2008

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis, Alasdair J Coles, D Alastair S Compston, et al.

Orphanet Journal of Rare Diseases|March 12, 2015

Recommendations for the development of rare disease drugs using the accelerated approval pathway and for qualifying biomarkers as primary endpointsEmil D Kakkis, Mary O'Donovan, Gerald Cox, et al.

Movement Disorders : Official Journal of the Movement Disorder Society|January 30, 2008

Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventionsChristopher G Goetz, Joanne Wuu, Michael P McDermott, et al.

Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 16, 2024

Nephrocalcinosis and kidney function in children and adults with X-linked hypophosphatemia: baseline results from a large longitudinal studyAnthony A Portale, Leanne Ward, Kathryn Dahir, et al.

Pageof 2